Dr Carolyn Luscombe, Head of Research and Development, has received an award at the HIV DART and Emerging Viruses 2018 in Miami, Florida for the presentation entitled“BIT225-009: Significant Immunological Outcomes after 12 weeks of BIT225 and Antiretroviral Therapy in an HIV-1 Phase 2 Clinical Trial”.
The award is an acknowledgement of the importance of the outcomes from the Phase 2 trial data presented, as well as the robustness of the science underlying the Company’s programs.
Thank you for your interest in Biotron.
Regards Michelle
Dr Michelle Miller | CEO & Managing Director | Biotron Limited
Award winning BIT, page-2
-
- There are more pages in this discussion • 127 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.87M |
Open | High | Low | Value | Volume |
3.3¢ | 3.3¢ | 3.2¢ | $17.40K | 542.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 17000 | 3.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.3¢ | 120000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 17000 | 0.031 |
8 | 342305 | 0.030 |
5 | 1208888 | 0.029 |
4 | 468000 | 0.028 |
2 | 537000 | 0.027 |
Price($) | Vol. | No. |
---|---|---|
0.033 | 120000 | 2 |
0.034 | 100000 | 1 |
0.035 | 317251 | 4 |
0.036 | 460000 | 2 |
0.037 | 537816 | 2 |
Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |